IHE ETF

IHE ETF
$102.98
Screen 5,700+ ETFsFind similar ETFs with lower fees
See inside every fund you own
$45/quarter Pro · Cancel anytime
X-ray my whole portfolio

Returns Overview

1 Month
+7.88%
3 Months
+14.26%
6 Months
+16.76%
YTD
+16.69%
1 Year
+51.05%
3 Years (annualized)
+19.45%
5 Years (annualized)
+11.27%
10 Years (annualized)
+8.87%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would IHE have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
Dow Jones US Select Pharmaceuticals Index(^DJSPHM)
This ETF (YTD)
+16.69%
Peer Avg (YTD)
+7.57%
vs Peers
+9.12%

IHE ETF Performance

IHE performance across multiple time periods: 1-month 7.88%, YTD 16.69%, 1-year 51.05%, 3-year 19.45%, 5-year 11.27%, 10-year 8.87%.

IHE returns outperform the peer average of 7.57% YTD. With an expense ratio of 0.38%, investors should weigh costs against performance when evaluating this ETF.

IHE vs another fund shows side-by-side returns. IHE alternatives are available in the ETF Screener.

Compare IHE

IHE vs SPYIHE vs QQQIHE vs VOOIHE vs VTIIHE vs IVVIHE vs SCHDIHE vs VYMIHE vs VXUS

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+7.88%N/A
3 Months+14.26%N/A
6 Months+16.76%N/A
1 Year+51.05%N/A
3 Years+19.45%N/A
5 Years+11.27%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized